JOHN R BENSON
Architects in Boston, MA
License number
Massachusetts 3692
Expiration Date
Aug 31, 2016
Type
Architect
Address
Address
Boston, MA 02129
Professional information
Principal Security Engineer At Emc Corporation
Position:
Principal Security Engineer at EMC Corporation
Location:
Greater Boston Area
Industry:
Computer & Network Security
Work:
EMC Corporation
since 2000
-
Principal Security Engineer
EMC
2000 - 2010
-
Principal Security Engineer
Inso Corp.
1998 - 2000
-
IT Manager
AT&T Lucent Technologies
- North Andover, MA 1994 - 1996
-
Member of Technical Staff
AT&T Bell Laboratories
- North Andover, MA Sep 1984 - Sep 1994
-
Member of Technical Staff
Education:
Tufts University 1987 - 1990
Master's degree, Mechanical Engineering Wentworth Institute of Technology 1980 - 1984
Bachelor's degree, Technical Science (Applied Physics)
Master's degree, Mechanical Engineering Wentworth Institute of Technology 1980 - 1984
Bachelor's degree, Technical Science (Applied Physics)
Program Head At Novartis Institutes For Biomedical Research
Position:
Program Head at Novartis institutes for Biomedical Research
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Novartis institutes for Biomedical Research
since 2003
-
Program Head
Enanta Pharmaceuticals
1999 - 2004
-
Director of Discovery and Molecular Biology
Operations At Ares Title
Position:
Operations at ARES Title
Location:
Greater Boston Area
Industry:
Real Estate
Work:
ARES Title
-
Operations
John Benson
Location:
Greater Boston Area
Industry:
Management Consulting
Dsrna Compositions And Methods For Treating Hpv Infections
US Patent:
2010024, Sep 30, 2010
Filed:
Mar 25, 2008
Appl. No.:
12/593202
Inventors:
John Benson - West Roxbury MA, US
Kevin Fitzgerald - Brookline MA, US
Birgit Bramlage - Kulmbach, DE
Pamela Tan - Kulmbach, DE
Hans-Peter Vornlocher - Bayreuth, DE
Kevin Fitzgerald - Brookline MA, US
Birgit Bramlage - Kulmbach, DE
Pamela Tan - Kulmbach, DE
Hans-Peter Vornlocher - Bayreuth, DE
International Classification:
C12N 15/86, C07H 21/02, A61K 31/7088
US Classification:
514 42, 536 221, 435455, 4353201
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) for treating human papilloma virus (HPV) infection. The dsRNA comprises an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of an HPV Target gene selected from the human E6AP gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by HPV infection and the expression of the E6AP gene using the pharmaceutical composition; and methods for inhibiting the expression of the HPV Target genes in a cell.
Provisioner At One Communications
Position:
provisioner at One Communications
Location:
Greater Boston Area
Industry:
Telecommunications
Work:
One Communications
-
provisioner
Education:
Zimbabwe Open University 1978 - 1982
Antagonism Of Human Formyl Peptide Receptor For Treatment Of Disease
US Patent:
2012023, Sep 13, 2012
Filed:
Jun 2, 2010
Appl. No.:
13/375599
Inventors:
John D. Benson - West Roxbury MA, US
Assignee:
NIKAN PHARMACEUTICALS, LLC - West Roxbury MA
International Classification:
A61K 38/13, A61P 17/00, A61P 11/06, A61P 29/00, A61P 9/10, A61P 1/00, A61P 1/04, A61P 11/00, A61P 17/10, C07K 7/64, A61P 17/06
US Classification:
514 17, 530321, 514 205, 514 186, 514 122
Abstract:
The present invention is directed to modulators of eosinophilic and neutrophilic function and the use of such modulators for treatment of eosinophil-associated and neutrophil-associated diseases.
Novel Therapeutic Uses Of Human Formyl Peptide Receptor Antagonists
US Patent:
2012021, Aug 23, 2012
Filed:
Mar 12, 2010
Appl. No.:
12/723163
Inventors:
John D. BENSON - West Roxbury MA, US
Assignee:
NIKAN PHARMACEUTICALS, LLC - West Roxbury MA
International Classification:
A01K 67/027, C12Q 1/02, A61P 1/00, A61K 38/13, A61P 11/00
US Classification:
800 9, 514 205, 435 29
Abstract:
The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.
Pole Unit Mechanism For Closing The Contacts In An Oil Circuit Breaker
US Patent:
3964338, Jun 22, 1976
Filed:
Apr 10, 1974
Appl. No.:
5/459846
Inventors:
John C. Benson - Hyde Park MA
George L. Hossfield - Walpole MA
George L. Hossfield - Walpole MA
Assignee:
Allis-Chalmers Corporation - Milwaukee WI
International Classification:
G05G 104
US Classification:
74520
Abstract:
A circuit breaker of the oil type having an operating mechanism for providing an improved force operation of the contact lift rod. The mechanism includes a linkage arrangement with a scissor-type toggle to provide a mechanical advantage for increasing the force for closing the contacts. In addition, the improved pull rod mechanism is particularly well adapted for location in relatively small enclosures.
Methods For Identifying Peptide Aptamers Capable Of Altering A Cell Phenotype
US Patent:
2003010, Jun 12, 2003
Filed:
Oct 3, 2002
Appl. No.:
10/263577
Inventors:
John Benson - West Roxbury MA, US
Sylvie Vincent - Somerville MA, US
Bradley Brasher - Natick MA, US
Sylvie Vincent - Somerville MA, US
Bradley Brasher - Natick MA, US
Assignee:
Enanta Pharmaceuticals - Watertown MA
International Classification:
G01N033/574, C12Q001/68, A61K048/00, C12N015/867
US Classification:
424/093210, 435/006000, 435/007230, 514/044000, 435/456000
Abstract:
The invention provides methods and compositions for screening and identifying peptide aptamers that can modulate a cell phenotype and further, can be used for the treatment of a disease involving a misregulated cell phenotype, such as, for example, a cancer.